Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Posts Flat Revenues, Widened Net Loss in Q3

NEW YORK, Nov. 1 - Caliper Technologies reported flat third-quarter revenue atop increased R&D spending and a slight jump in net loss.

 

For the period ended Sept. 30, total revenue was $6.6 million, largely unchanged from the same quarter one year ago, Caliper said. Broken down, revenue from product sales during the quarter increased to $2.3 million from $1.6 million last year, while receipts from licensing fees fell to $2.4 million from $3.0 million.

 

Third-quarter R&D spending increased to $10.9 million from just under $10 million year over year as total costs and expenses in the period inched up to $17.4 million from $17.2 million.

 

Consequently, net loss in the third quarter went up to $9.4 million, or $.38 per share, from $8.4 million, or $.35 per share, last year, according to Caliper.

 

The company said it had roughly $126.4 million in cash, cash equivalents, and short-term marketable securities as of Sept. 30.

 

Click here for more information.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.